NCT01148446 - R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL | Biotech Hunter

Enrollment

226

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2006

Conditions

Elderly Patients (>65 Years)Diffuse Large B Cell Lymphoma (DLBCL)

Interventions

DRUG

Cyclophosphamide

750 mg/mq IV, day 1

DRUG

Cyclophosphamide

50 mg/mq IV, day 1

DRUG

Doxorubicin

50 mg/mq IV, day1

DRUG

Vincristine

1,4 mg/mq (max 2 mg)IV, day 1

DRUG

Prednisone

75 mg/mq IV, days 1-5

DRUG

Prednisone

60 mg/mq IV/PO, days 1-5

DRUG

Epirubicin

50 mg/mq IV, day 1

DRUG

Vinblastine

5 mg/mq IV, day 1

DRUG

Rituximab

375 mg/mq IV, day 1

DRUG

G-CSF

300 µg tot., SC; days 7-11

Trial Locations (11)

25123

S.C. di Ematologia, Spedali Civili, Brescia

Unknown

Ospedale di Vigevano, Vigevano

Ospedale Garibaldi-Nesima, Catania

Ospedale civile Divisione di Ematologia, Civitanova Marche (MC)

Ospedale San Sebastiano, Correggio (RE)

Presidio Ospedaliero Annunziata, Cosenza

Istituto Vito Fazzi, Lecce

Azienda Ospedaliera Policlinico, Modena

AO Arcispedale S.Maria Nuova Ematologia, Reggio Emilia

Ospedale civile DH oncologico, Sassuolo (MO)

Ospedale San Giovanni Battista - Molinette, Torino

All Listed Sponsors

lead

Fondazione Italiana Linfomi - ETS

OTHER